【24h】

Setting Bench Mark Dose Limits for Perfluorinated Substances with Epidemiological Data

机译:使用流行病学数据设置全氟化物的基准剂量限值

获取原文

摘要

Background/Aim: Limits set for exposure to PFOA (perfluoro-octanoic acid) and other perfluorinated alkyl substances (PFAS), whether as daily intake, water concentrations or serum concentrations, have mostly relied on extrapolation from animal experimental data, with attendant uncertainties. Using the largest available database with a wide range of serum PFOA concentrations, Bench Mark Doses (BMD) as a basis for limits are proposed using the epidemiological data directly. The European Food Standards Authority is also proposing BMDs for these chemicals drawing on epidemiological data. Methods: Using the most replicated health effect associated with serum PFOA -increased lipids, BMD methods have been applied to the largest suitable dataset, the C8 study. With no strong evidence of a threshold, at the lower end of the range (1 to 30 ng/ml) the relation between lipids and serum PFOA is close to linear, so a benchmark limit for hypocholesteremia (total cholesterol>240 mg/dl) can be established for a given additional risk of this condition. A benchmark response rate (BMR) of a 1% change in response has been used for some epidemiological data and is used here. Results: Serum PFOA in 54,000 adults was median 28 ng/ml (1-99 pctile range 3 to 889). The BMD for PFOA at a 1% BMR, from models not including other PFAS, in terms of serum concentration of PFOA was 4.1 ng/ml, with corresponding BMDL at the lower confidence level of 2.8 ng/ml. PFOA and other PFAS are correlated and models with both exposures yielded shallower slopes and higher BMD values. Conclusions: A BMDL for PFOA of 2.8 ng/ml is close to population background average serum levels, although the BMDL is sensitive to several factors: selecting either change in average cholesterol or risk of high cholesterol, the arbitrary choice of BMR which should reflect the severity of the outcome (other have chosen 5%), and whether other PFAS are included. The inclusion of other PFAS leads to substantially higher BMDL values.
机译:背景/目的:用于暴露于PFOA(全氟辛酸)和其他全氟化烷基物质(PFAS)的限制,无论是每日摄入,水浓度还是血清浓度,大多数依赖于从动物实验数据的外推,具有伴随的不确定性。使用具有宽范围血清PFOA浓度的最大可用数据库,基准标记剂量(BMD)是直接使用流行病学数据的基础。欧洲食品标准机构还在对流行病学数据提取这些化学品的BMDS提出。方法:使用与血清PFOA相关的最复杂的健康效果 - 增加脂质,BMD方法已应用于最大的合适数据集,C8研究。在没有强有力的阈值证据,在范围的下端(1至30ng / ml),脂质和血清PFOA之间的关系接近线性,因此脱胆固醇血症的基准限制(总胆固醇> 240mg / dl)可以为这种情况的给定的额外风险建立。响应的1%变化的基准响应率(BMR)已用于某些流行病学数据并在此处使用。结果:54,000名成人中的血清PFOA是28 ng / ml(1-99个PCTILE范围3至889)。在1%BMR的PFOA的BMD,从不包括其他PFA的模型,在PFOA的血清浓度方面是4.1ng / mL,具有相应的BMDL,距离置位为2.8ng / ml。 PFOA和其他PFA是相关的,并且具有两种曝光的模型产生较浅的斜率和更高的BMD值。结论:2.8ng / ml的PFOA的BMDL接近人口背景平均血清水平,尽管BMDL对若干因素敏感:选择平均胆固醇或高胆固醇风险的变化,BMR的任意选择应该反映结果的严重程度(其他已选择5%),以及是否包括其他PFA。将其他PFA的包含导致基本上更高的BMDL值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号